EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir

Alessandro Paciaroni, Valeria Libera, Francesca Ripanti iD, Andrea Orecchini, Caterina Petrillo, Daniela Francisci, Elisabetta Schiaroli, Samuele Sabbatini iD, Anna Gidari iD, Elisa Bianconi iD, Antonio Macchiarulo iD, Rohanah Hussain und 8 weitere

International Journal of Molecular Sciences · 23.03.2023 · 24 (7) · 6062

DOI: 10.3390/ijms24076062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.03.2023. Verfasst von Alessandro Paciaroni und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics and Geology, University of Perugia, Via Alessandro Pascoli, 06123 Perugia, Italy. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Cassa di Risparmio di Perugia, European Union’s Horizon 2020 research and innovation program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The main protease (Mpro or 3CLpro) is an enzyme that is evolutionarily conserved among different genera of coronaviruses. As it is essential for processing and maturing viral polyproteins, Mpro has been identified as a promising target for the development of broad-spectrum drugs against coronaviruses. Like SARS-CoV and MERS-CoV, the mature and active form of SARS-CoV-2 Mpro is a dimer composed of identical subunits, each with a single active site. Individual monomers, however, have very low or no catalytic activity. As such, inhibition of Mpro can be achieved by molecules that target the substrate binding pocket to block catalytic activity or target the dimerization process. In this study, we investigated GC376, a transition-state analog inhibitor of the main protease of feline infectious peritonitis coronavirus, and Nirmatrelvir (NMV), an oral, bioavailable SARS-CoV-2 Mpro inhibitor with pan-human coronavirus antiviral activity. Our results show that both GC376 and NMV are capable of strongly binding to SARS-CoV-2 Mpro and altering the monomer-dimer equilibrium by stabilizing the dimeric state. This behavior is proposed to be related to a structured hydrogen-bond network established at the Mpro active site, where hydrogen bonds between Ser1’ and Glu166/Phe140 are formed in addition to those achieved by the latter residues with GC376 or NMV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansCysteine EndopeptidasesProtease InhibitorsAntiviral AgentsMolecular Docking SimulationLactamsLeucineSulfonic AcidsCoronavirus 3C Proteases

Stichwörter der Autor:innen

COVID-19PF-07321332PaxlovidSARS-CoV-2circular dichroismdimerizationinhibitormain proteasemicroscale thermophoresissmall angle X-ray scattering

Substanzen

Cysteine EndopeptidasesProtease InhibitorsAntiviral AgentsGC376LactamsLeucineSulfonic Acids3C-like proteinase, SARS-CoV-2Coronavirus 3C Proteases

Autor:innen und Institutionen

  • Department of Physics and Geology, University of Perugia, Via Alessandro Pascoli, 06123 Perugia, Italy.
  • Istituto Officina dei Materiali-IOM, National Research Council-CNR, Via Alessandro Pascoli, 06123 Perugia, Italy.
  • Department of Medicine and Surgery, Clinic of Infectious Diseases, University of Perugia, Piazzale Gambuli, 06129 Perugia, Italy.
  • Department of Medicine and Surgery, Medical Microbiology Section, University of Perugia, Piazzale Gambuli, 06129 Perugia, Italy.
  • Department of Pharmaceutical Sciences, University of Perugia, Via del Liceo, 06123 Perugia, Italy.
  • Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0DE, UK.

ORCID-Profile: Francesca Ripanti, Samuele Sabbatini, Anna Gidari, Elisa Bianconi, Antonio Macchiarulo, Lucia Silvestrini, Paolo Moretti, Yessica Roque, Paolo Mariani, Lucia Comez, Francesco Spinozzi

Förderung

  • Fondazione Cassa di Risparmio di Perugia
  • European Union’s Horizon 2020 research and innovation program

Zitieren

APA

Paciaroni, A., Libera, V., Ripanti, F., Orecchini, A., Petrillo, C., Francisci, D., Schiaroli, E., Sabbatini, S., Gidari, A., Bianconi, E., Macchiarulo, A., Hussain, R., Silvestrini, L., Moretti, P., Belhaj, N., Vercelli, M., Roque, Y., Mariani, P., Comez, L., & Spinozzi, F. (2023). Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir. International Journal of Molecular Sciences, 24(7), 6062. https://doi.org/10.3390/ijms24076062

Vancouver

Paciaroni A, Libera V, Ripanti F, Orecchini A, Petrillo C, Francisci D, et al. Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir. International Journal of Molecular Sciences. 2023;24(7):6062. doi:10.3390/ijms24076062

BibTeX
@article{Paciaroni2023,
  author = {Paciaroni, Alessandro and Libera, Valeria and Ripanti, Francesca and Orecchini, Andrea and Petrillo, Caterina and Francisci, Daniela and Schiaroli, Elisabetta and Sabbatini, Samuele and Gidari, Anna and Bianconi, Elisa and Macchiarulo, Antonio and Hussain, Rohanah and Silvestrini, Lucia and Moretti, Paolo and Belhaj, Norhan and Vercelli, Matteo and Roque, Yessica and Mariani, Paolo and Comez, Lucia and Spinozzi, Francesco},
  title = {Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {7},
  pages = {6062},
  doi = {10.3390/ijms24076062}
}
Kostenlos starten →